Dextromethorphan inhibition of voltage-gated proton currents in BV2 microglial cells

Neuroscience Letters

Volumn 516, Issue 1, 2012, Pages 94-98

  Song, Jin Ho ^a   Yeh, Jay Z ^b  

^a Chung Ang University   (South Korea)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

3 Hydroxymorphinan; Dextromethorphan; Dextrorphan; Microglial BV2 cell; Voltage gated proton channel

Indexed keywords

3 HYDROXYMORPHINAN HYDROBROMIDE; DEXTROMETHORPHAN; DEXTROMETHORPHAN METHIODIDE; DEXTRORPHAN; ION CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED PROTON CURRENT;

ARTICLE; CHANNEL GATING; CONTROLLED STUDY; ELECTRIC POTENTIAL; IC 50; INHIBITION KINETICS; ION CURRENT; MICROGLIA; MICROGLIA BV2 CELL; PH; PRIORITY JOURNAL;

ANIMALS; ANTITUSSIVE AGENTS; CELL LINE; DEXTROMETHORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; ION CHANNEL GATING; ION CHANNELS; MICE; MICROGLIA;

EID: 84860251594     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.065     Document Type: Article

References (23)

1. Chechneva O.V., Mayrhofer F., Daugherty D.J., Pleasure D.E., Hong J.S., Deng W. Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord. Neurobiol. Dis. 2011, 44:63-72.
2. Cole A.E., Eccles C.U., Aryanpur J.J., Fisher R.S. Selective depression of N-methyl-d-aspartate-mediated responses by dextrorphan in the hippocampal slice in rat. Neuropharmacology 1989, 28:249-254.
3. Damaj M.I., Flood P., Ho K.K., May E.L., Martin B.R. Effect of dextrometorphan and dextrorphan on nicotine and neuronal nicotinic receptors: in vitro and in vivo selectivity. J. Pharmacol. Exp. Ther. 2005, 312:780-785.
4. DeCoursey T.E., Morgan D., Cherny V.V. The voltage dependence of NADPH oxidase reveals why phagocytes need proton channels. Nature 2003, 422:531-534.
5. DeCoursey T.E. Voltage-gated proton channels. Cell. Mol. Life Sci. 2008, 65:2554-2573.
6. El Chemaly A., Okochi Y., Sasaki M., Arnaudeau S., Okamura Y., Demaurex N. VSOP/Hv1 proton channels sustain calcium entry neutrophil migration, and superoxide production by limiting cell depolarization and acidification. J. Exp. Med. 2010, 207:129-139.
7. + channels expressed in Xenopus oocytes. Eur. J. Pharmacol. 2007, 564:7-17.
8. Li G., Cui G., Tzeng N.S., Wei S.J., Wang T., Block M.L., Hong J.S. Femtomolar concentrations of dextromethorphan protect mesencephalic dopaminergic neurons from inflammatory damage. FASEB J. 2005, 19:489-496.
9. Liu S.L., Li Y.H., Shi G.Y., Tang S.H., Jiang S.J., Huang C.W., Liu P.Y., Hong J.S., Wu H.L. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice. Cardiovasc. Res. 2009, 82:161-169.
10. Liu Y., Qin L., Li G., Zhang W., An L., Liu B., Hong J.S. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. J. Pharmacol. Exp. Ther. 2003, 305:212-218.
11. Morgan D., Cherny V.V., Murphy R., Katz B.Z., DeCoursey T.E. The pH dependence of NADPH oxidase in human eosinophils. J. Physiol. 2005, 569:419-431.
12. Netzer R., Pflimlin P., Trube G. Dextromethorphan blocks N-methyl-d-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons. Eur. J. Pharmacol. 1993, 238:209-216.
13. Okochi Y., Sasaki M., Iwasaki H., Okamura Y. Voltage-gated proton channel is expressed on phagosomes. Biochem. Biophys. Res. Commun. 2009, 382:274-279.
14. Ramsey I.S., Ruchti E., Kaczmarek J.S., Clapham D.E. Hv1 proton channels are required for high-level NADPH oxidase-dependent superoxide production during the phagocyte respiratory burst. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7642-7647.
15. Schadel M., Wu D., Otton S.V., Kalow W., Sellers E.M. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J. Clin. Psychopharmacol. 1995, 15:263-269.
16. Song J.H., Marszalec W., Kai L., Yeh J.Z., Narahashi T. Antidepressants inhibit proton currents and tumor necrosis factor-α production in BV2 microglial cells. Brain Res. 2012, 1435:15-23.
17. Steinberg G.K., Bell T.E., Yenari M.A. Dose escalation safety and tolerance study of the N-methyl-d-aspartate antagonist dextromethorphan in neurosurgery patients. J. Neurosurg. 1996, 84:860-866.
18. Szekely J.I., Sharpe L.G., Jaffe J.H. Induction of phencyclidine-like behavior in rats by dextrorphan but not dextromethorphan. Pharmacol. Biochem. Behav. 1991, 40:381-386.
19. Thomas D.M., Kuhn D.M. MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Res. 2005, 1050:190-198.
20. Werling L.L., Lauterbach E.C., Calef U. Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. Neurologist 2007, 13:272-293.
21. Zhang W., Wang T., Qin L., Gao H.M., Wilson B., Ali S.F., Zhang W., Hong J.S., Liu B. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J. 2004, 18:589-591.
22. Zhang W., Qin L., Wang T., Wei S.J., Gao H.M., Liu J., Wilson B., Liu B., Zhang W., Kim H.C., Hong J.S. 3-Hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity. FASEB J. 2005, 19:395-397.
23. Zhang W., Shin E.J., Wang T., Lee P.H., Pang H., Wie M.B., Kim W.K., Kim S.J., Huang W.H., Wang Y., Zhang W., Hong J.S., Kim H.C. 3-Hydroxymorphinan a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP-elicited damage both in vivo and in vitro. FASEB J. 2006, 20:2496-2511.